Table 5.
Parameter | Multivariate (CV mortality) | Multivariate (all-cause mortality) | ||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Age (per 1 year) | 1.045 (1.010–1.082) | 0.011 | 1.055 (1.033–1.077) | < 0.001 |
Male gender (male vs female) | 2.119 (1.157–3.882) | 0.015 | 1.527 (1.061–2.197) | 0.023 |
Diabetes (%) | – | 0.443 | – | 0.619 |
Hypertension (%) | 0.387 (0.181–0.826) | 0.014 | – | 0.059 |
Dyslipidemia (yes or no) | – | 0.119 | – | 0.681 |
Stroke/TIA (%) | – | 0.855 | – | 0.950 |
Heart failure (%) | 2.510 (1.156–5.450) | 0.020 | 2.312 (1.407–3.800) | 0.001 |
Smoking (ever vs no) | 0.932 (0.402–2.161) | 0.932 | – | 0.862 |
Heart rate (per beat/minute) | – | 0.511 | – | 0.207 |
Body mass index | – | 0.970 | – | 0.926 |
CHADS2 score | – | 0.260 | – | 0.607 |
CHA2DS2-VASc score | 1.600 (1.254–2.040) | < 0.001 | 1.503 (1.300–1.739) | < 0.001 |
Medications | ||||
Aspirin use | – | 0.796 | – | 0.895 |
Beta blocker use | – | 0.629 | – | 0.834 |
Calcium channel blocker use | – | 0.788 | – | 0.636 |
ACEI use | – | 0.706 | – | 0.568 |
ARB use | – | 0.524 | 0.506 (0.342–0.748) | 0.001 |
Diuretic use | – | 0.206 | – | 0.125 |
HR hazard ratio, CI confidence interval, CV cardiovascular, other abbreviations as in Table 1.